Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
Mckesson Corp (MCK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,312,164 | $1,135,494,239 | -5% | 0.61% |
| 2. | AQR Capital Management Cliff Asness | 907,472 | $784,246,271 | -2% | 0.36% |
| 3. | Lone Pine Capital Stephen Mandel | 392,224 | $339,414,961 | 2.71% | |
| 4. | SurgoCap Partners Mala Gaonkar | 348,732 | $301,778,724 | -17% | 10.08% |
| 5. | Farallon Capital Thomas Steyer | 234,300 | $202,753,848 | -22% | 1.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $144.52 | 692 | $100,006.66 | 6,843 | 2016-11-30 | Filing | |
| $136.36 | 100 | $13,635.52 | 2,005 | 2016-11-02 | Filing | |
| $136.35 | 900 | $122,715.00 | 1,905 | 2016-11-02 | Filing | |
| $156.21 | 1,000 | $156,211.40 | 1,000 | 2016-02-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $775.13 | 8,463 | $6,559,925.19 | 14,382 | 2026-06-17 | Filing | |
| $763.00 | 4,929 | $3,760,827.00 | 22,845 | 2026-06-09 | Filing | |
| $764.00 | 133 | $101,612.00 | 632 | 2026-06-05 | Filing | |
| $735.27 | 699 | $513,953.73 | 2,268 | 2026-06-02 | Filing | |
| $735.50 | 123 | $90,466.50 | 2,967 | 2026-06-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,337 | $1,766,011 | 1.4% | |
| 2. | 1,548 | $1,169,669 | 0.25% | |
| 3. | 726 | $548,566 | 0.36% | |
| 4. | 714 | $539,498 | 0.01% | |
| 5. | 531 | $401,224 | 0.04% |
News See All
Is McKesson Corporation (MCK) A Good Stock To Buy Now?
Is MCK a good stock to buy? We came across a bullish thesis on McKesson Corporation on r/ValueInvesting by OnTheStreetwithLou. In this article, we will summarize the bulls’ thesis on MCK.
Top 10 Strong Buy Stocks to Invest In
Strong Buy-rated stocks are getting more attention as investors look for names where Wall Street optimism is backed by earnings momentum, quality, and company-specific catalysts.
Here is What Analysts Are Saying About McKesson Corporation (MCK)
McKesson Corporation (NYSE:MCK) is one of top cheap stocks with Strong Buy ratings on Wall Street.
Top 10 Cheap Stocks With Strong Buy Ratings on Wall Street
On June 1, Tom Lee, Fundstrat managing partner and head of research, and Fundstrat Capital CIO, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends, the market outlook, and more...
What Makes McKesson Corporation (MCK) an Attractive Bet?
TCW Funds, an investment management firm, published its first-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter is available to download here.
McKesson Corporation (MCK) Highlights Resilience as Its Core Drug Distribution Network Stands the Test of Time
Eagle Point Capital, an investment firm, released its “Spring 2026 Portfolio Update" investor letter. A copy of the letter can be downloaded here.
McKesson Corporation (MCK) Surged 50% on Strong Earnings Growth and Resilient Drug Distribution Model
Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
14 Best Dividend Stocks to Buy for Steady Growth
Investors looking for shelter from market volatility have been moving toward dividend stocks this year.
McKesson Corporation (NYSE:MCK) Q4 2026 Earnings Call Transcript
Operator: Welcome to McKesson's Fourth Quarter Fiscal 2026 Earnings Conference Call. Please be advised that today's conference is being recorded.
Hedge Fund Resource Center